Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Gastroenterologia Y Hepatologia|October 9, 2018
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel diseaseJordi Guardiola, Triana Lobatón, Elena Cerrillo, et al.Clinical and Translational Gastroenterology|October 31, 2019
Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's DiseaseInés Moret-Tatay, Elena Cerrillo, Esteban Sáez-González, et al.Clinical and Translational Gastroenterology|October 25, 2021
Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic ImplicationsInés Moret-Tatay, Elena Cerrillo, David Hervás, et al.Digestive Diseases and Sciences|January 4, 2019
Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for RelapseMarisa Iborra, Julia Herreras, Marta Maia Boscá-Watts, et al.Biomedicines|November 27, 2025
Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn's Disease: An Observational StudyAlejandro Mínguez, Beatriz Mateos, Marisa Iborra, et al.Journal of Clinical Apheresis|May 10, 2017
Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokinesBelén Beltrán, Esteban Sáez-González, Inés Moret, et al.Digestive Diseases (Basel, Switzerland)|August 28, 2018
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's DiseaseBelén Beltrán, Marisa Iborra, Esteban Sáez-González, et al.Gastroenterologia Y Hepatologia|September 13, 2024
Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with IBD. Efficacy and adjusted regimen in real worldAlejandro Mínguez, Elena Coello, Alejandro Garrido, et al.Scientific Reports|October 21, 2020
Real-life experience with 4 years of golimumab persistence in ulcerative colitis patientsMarisa Iborra, Natalia García-Morales, Saoia Rubio, et al.Journal of Crohn'S & Colitis|August 22, 2024
Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA RegistryMarisa Iborra, Berta Caballol, Alejandro Garrido, et al.Pageof 3